|
"hurvitz sara a"的相關文件
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-12-21T23:17:41Z |
Matching-adjusted indirect comparison of ribociclib plus fulvestrant versus palbociclib plus letrozole as first-line treatment of hr+/her2− advanced breast cancer
|
Fasching, Peter A.; Delea, Thomas E.; YEN-SHEN LU; De Boer, Richard; Hurvitz, Sara A.; Moynahan, Aaron; Chandiwana, David; Lanoue, Brad; Hu, Huilin; Thuerigen, Astrid; O’shaughnessy, Joyce |
| 國立臺灣大學 |
2015 |
A phase II, open-label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC)
|
Parton, Marina; Bardia, Aditya; Kummel, Sherko; Estevez, Laura G.; Huang, Chiun-Sheng; Castan, Javier Cortes; Borrego, Manuel Ruiz; Telli, Melinda L.; Lluch, Ana; Lopez, Rafael; Beck, J. Thaddeus; Ismail-Khan, Roohi; Chen, Shin-Cheh; Hurvitz, Sara A.; Mayer, Ingrid A.; Atienza, Rolando S.; Cameron, Scott; Krygowski, Mizue; Kim, Sung-Bae; 黃俊升 |
| 國立臺灣大學 |
2012 |
LUX-breast 1: Randomized, phase III trial of afatinib and vinorelbine versus trastuzumab and vinorelbine in patients with HER2-overexpressing metastatic breast cancer (MBC) failing one prior trastuzumab treatment.
|
Harbeck, Nadia; Im, Seock-Ah; Huang, Chiun-Sheng; Im, Young-Hyuck; Xu, Binghe; Hurvitz, Sara A.; Lee, Keun-Seok; Ahn, Jin-Hee; Mehta, Ajay O.; Arora, Rajender Singh; Sun, Qiang; Qin, Shukui; Jacob, Linu Abraham; Jassem, Jacek; Staroslawka, Elzbieta; Sufliarsky, Jozef; Wojtukiewicz, Marek; Lahogue, Annick; Uttenreuther-Fischer, Martina Maria; Piccart-Gebhart, Martine J.; 黃俊升 |
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
|
